The pulmonary dendritic/langerhans cell in immunity and disease

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Dendritic cells are potent antigen-presenting cells located in strategic positions in the lung, enabling them to be a first line of defense against inhaled pathogens. These cells are a critical component of the immune system, and surveillance of tissues for emerging tumors, infectious pathogens, and cellular breakdown products relies to a large extent on dendritic cells. Langerhans cells are a specialized type of dendritic cell, distributed in a subepithelial location in the airways. At least 1 other population of non-Langerhans type of dendritic cells exists in the lung, distributed in the interstitial and pleural spaces. These phagocytic dendritic cells are able to activate upon contact with antigen or exposure to proinflammatory factors. Upon activation, they become migratory and transport antigens from the airways or distal lung spaces to the draining lymph nodes, where processed antigen is presented to T cells. In addition to eliciting specific T-cell responses to antigens, pulmonary dendritic cells also induce tolerance to innocuous antigens through the induction of regulatory T cells. Defective dendritic cell function plays an important role in numerous lung diseases. Understanding the origin, function, and interactions between dendritic cells and other resident airway and interstitial cells may provide key insight into many lung diseases, including asthma and interstitial lung diseases. Abnormalities in dendritic cell function have been implicated in the development of cancer, and ongoing research suggests that these cells may be used as an immune adjuvant to enable eradication of established lung cancer or prevent the development of metastases.

Original languageEnglish (US)
Pages (from-to)84-89
Number of pages6
JournalClinical Pulmonary Medicine
Volume12
Issue number2
DOIs
StatePublished - Mar 2005

Fingerprint

Langerhans Cells
Dendritic Cells
Immunity
Lung
Antigens
Lung Diseases
T-Lymphocytes
Interstitial Lung Diseases
Antigen-Presenting Cells
Regulatory T-Lymphocytes
Phagocytes
Immune System
Lung Neoplasms
Neoplasms
Asthma
Lymph Nodes
Neoplasm Metastasis

Keywords

  • Acquired immunity
  • Allergy
  • Antigens
  • Dendritic cells
  • Langerhans cells

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

The pulmonary dendritic/langerhans cell in immunity and disease. / Vassallo, Robert.

In: Clinical Pulmonary Medicine, Vol. 12, No. 2, 03.2005, p. 84-89.

Research output: Contribution to journalArticle

@article{67b6e463f0c94f1da016145685bbd73a,
title = "The pulmonary dendritic/langerhans cell in immunity and disease",
abstract = "Dendritic cells are potent antigen-presenting cells located in strategic positions in the lung, enabling them to be a first line of defense against inhaled pathogens. These cells are a critical component of the immune system, and surveillance of tissues for emerging tumors, infectious pathogens, and cellular breakdown products relies to a large extent on dendritic cells. Langerhans cells are a specialized type of dendritic cell, distributed in a subepithelial location in the airways. At least 1 other population of non-Langerhans type of dendritic cells exists in the lung, distributed in the interstitial and pleural spaces. These phagocytic dendritic cells are able to activate upon contact with antigen or exposure to proinflammatory factors. Upon activation, they become migratory and transport antigens from the airways or distal lung spaces to the draining lymph nodes, where processed antigen is presented to T cells. In addition to eliciting specific T-cell responses to antigens, pulmonary dendritic cells also induce tolerance to innocuous antigens through the induction of regulatory T cells. Defective dendritic cell function plays an important role in numerous lung diseases. Understanding the origin, function, and interactions between dendritic cells and other resident airway and interstitial cells may provide key insight into many lung diseases, including asthma and interstitial lung diseases. Abnormalities in dendritic cell function have been implicated in the development of cancer, and ongoing research suggests that these cells may be used as an immune adjuvant to enable eradication of established lung cancer or prevent the development of metastases.",
keywords = "Acquired immunity, Allergy, Antigens, Dendritic cells, Langerhans cells",
author = "Robert Vassallo",
year = "2005",
month = "3",
doi = "10.1097/01.cpm.0000156277.59474.6c",
language = "English (US)",
volume = "12",
pages = "84--89",
journal = "Clinical Pulmonary Medicine",
issn = "1068-0640",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The pulmonary dendritic/langerhans cell in immunity and disease

AU - Vassallo, Robert

PY - 2005/3

Y1 - 2005/3

N2 - Dendritic cells are potent antigen-presenting cells located in strategic positions in the lung, enabling them to be a first line of defense against inhaled pathogens. These cells are a critical component of the immune system, and surveillance of tissues for emerging tumors, infectious pathogens, and cellular breakdown products relies to a large extent on dendritic cells. Langerhans cells are a specialized type of dendritic cell, distributed in a subepithelial location in the airways. At least 1 other population of non-Langerhans type of dendritic cells exists in the lung, distributed in the interstitial and pleural spaces. These phagocytic dendritic cells are able to activate upon contact with antigen or exposure to proinflammatory factors. Upon activation, they become migratory and transport antigens from the airways or distal lung spaces to the draining lymph nodes, where processed antigen is presented to T cells. In addition to eliciting specific T-cell responses to antigens, pulmonary dendritic cells also induce tolerance to innocuous antigens through the induction of regulatory T cells. Defective dendritic cell function plays an important role in numerous lung diseases. Understanding the origin, function, and interactions between dendritic cells and other resident airway and interstitial cells may provide key insight into many lung diseases, including asthma and interstitial lung diseases. Abnormalities in dendritic cell function have been implicated in the development of cancer, and ongoing research suggests that these cells may be used as an immune adjuvant to enable eradication of established lung cancer or prevent the development of metastases.

AB - Dendritic cells are potent antigen-presenting cells located in strategic positions in the lung, enabling them to be a first line of defense against inhaled pathogens. These cells are a critical component of the immune system, and surveillance of tissues for emerging tumors, infectious pathogens, and cellular breakdown products relies to a large extent on dendritic cells. Langerhans cells are a specialized type of dendritic cell, distributed in a subepithelial location in the airways. At least 1 other population of non-Langerhans type of dendritic cells exists in the lung, distributed in the interstitial and pleural spaces. These phagocytic dendritic cells are able to activate upon contact with antigen or exposure to proinflammatory factors. Upon activation, they become migratory and transport antigens from the airways or distal lung spaces to the draining lymph nodes, where processed antigen is presented to T cells. In addition to eliciting specific T-cell responses to antigens, pulmonary dendritic cells also induce tolerance to innocuous antigens through the induction of regulatory T cells. Defective dendritic cell function plays an important role in numerous lung diseases. Understanding the origin, function, and interactions between dendritic cells and other resident airway and interstitial cells may provide key insight into many lung diseases, including asthma and interstitial lung diseases. Abnormalities in dendritic cell function have been implicated in the development of cancer, and ongoing research suggests that these cells may be used as an immune adjuvant to enable eradication of established lung cancer or prevent the development of metastases.

KW - Acquired immunity

KW - Allergy

KW - Antigens

KW - Dendritic cells

KW - Langerhans cells

UR - http://www.scopus.com/inward/record.url?scp=14944374555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14944374555&partnerID=8YFLogxK

U2 - 10.1097/01.cpm.0000156277.59474.6c

DO - 10.1097/01.cpm.0000156277.59474.6c

M3 - Article

AN - SCOPUS:14944374555

VL - 12

SP - 84

EP - 89

JO - Clinical Pulmonary Medicine

JF - Clinical Pulmonary Medicine

SN - 1068-0640

IS - 2

ER -